ALV-001

N/A

Report date: 2025/02/05 17:04:54

Base Information

Drug NameALV-001
Drug Alias NameEP-B2 endoprotease derivative (Alvine)ALV-001
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionGliadin modulatorsCysteine proteases stimulants
TargetsGliadinCathepsin BCysteine proteases
Therapy Area/IndicationsFunctional bowel disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAlvine Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlvine Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsFunctional bowel disorder

Other Information

ATC CodeN/A
Related LinksN/A